Covaxin administered in India in large numbers is yet to be approved for travel to the US
Browsing: Covaxin
Many Indian Americans with relatives in India vaccinated with Covaxin anxious about WHO approval
India leads with 489 million doses, while Bhutan has achieved 70% coverage — highest in the region
Recently published results of the phase 3 clinical trial for Covaxin shows that it is 93% effective in preventing serious disease.
The Biden Administration would have to go beyond supporting the vaccines already in use in this country and need an “all of the above” approach.
Dr. Shankar Musunuri, Chairman, CEO and Co-Founder of Ocugen, speaks to The American Bazaar.